VVT Medical Inc.

Streamlined varicose vein treatment products with no reported pain or complications

VVT Technologies Inc. (TSXV:VVTM)

  • Develops, manufactures, and distributes minimally invasive, non-thermal, non-tumescent (NT-NT) solutions for the treatment of vein diseases, starting with varicose veins

  • $60B addressable market - only 2% of which ($1.2B) is being captured today because 98% of patients don’t proceed with treatment due to fears of pain and complications

  • FDA-cleared (USA), CE-Marked (EU) and clearances in India, Brazil, Australia, Korea and the UAE

  • Enables safe, office-based procedures with no anesthetics, no downtime and no reported pain or side effects

  • 3,800 procedures completed with no reported pain

  • Distribution with Northwell Health, one of the largest health networks in the USA (1,000+ clinics and hospitals), with one of the country’s leading venous disease programs

  • $25M distribution agreement with Methahparm

  • $3.7M distribution deal in India

  • CPT code for insurance reimbursement in the USA expected in Q1 2026 (patient-paid until then)

Key Stats:

Location: Vancouver, Canada and Kfar Saba, Israel

  • Founded: 2007

  • Employees: Approximately 10–50

  • Web Site: www.vvtmed.com

  • Contact: +972-9-766-0480 | info@vvtmed.com

Stylized text spelling 'VVT' in gradient shades of blue and gray, a logo for VVT Medical, a varicose vein medical device company. VVT stands for validated, venous technology
VVTM stock price by TradingView
VVTM fundamentals by TradingView
Corporate Presentation (click to view)

Corporate Presentation (click to view)

Product Demonstration (click to view)

Product Demonstration (click to view)

ScleroSafe: For smaller, peripheral veins Synergistic, catheter-based products to treat the widest range of vein diameters in the market. Short in-clinic procedure with no reported pain or complications

ScleroSafe: For smaller, peripheral veins Synergistic, catheter-based products to treat the widest range of vein diameters in the market. Short in-clinic procedure with no reported pain or complications

V-Block: For Larger Diameter Veins Implanted in legs

V-Block: For Larger Diameter Veins Implanted in legs

Physician marks the vein to be treated

Physician marks the vein to be treated

Doctor examines leg minutes after treatment

Doctor examines leg minutes after treatment

Varicosities: Before and After

Varicosities: Before and After

Small saphenous treatment with complicated behind-the-knee access: Before and After

Small saphenous treatment with complicated behind-the-knee access: Before and After

Single-use product - No capital expenditure required by physicians

Single-use product - No capital expenditure required by physicians

TSX Venture Exchange Opening - November 26, 2025

TSX Venture Exchange Opening - November 26, 2025

Meet the Team

  • Portrait of Erez Tetro, CEO of VVT Medical. He is a smiling man in a suit and tie, standing indoors near a window.

    Erez Tetro

    CEO

    20+ years in healthcare industry

    Prev. J&J’s Ethicon division, specializing in surgical technologies and solutions

  • A smiling man with dark hair and a beard outdoors, with greenery in the background.

    Dor Sneh

    CFO

    Prev. Group CFO at Water Ways Technologies (TSXV:WWT)

    10+ years in senior finance roles

  • A middle-aged man with glasses, short gray hair, and a light blue button-down shirt smiling with arms crossed, standing against a plain light background.

    Eyal Alon

    VP, SALES

    20+ year track record of successfully launching medical devices products and leading international sales teams at J&J and diverse healthcare settings

    B.Sc in Mechanical Engineering, BioMechanics

  • Woman with brown hair, wearing a light blue blouse and a yellow headband with a blue flower, posing against a gray background.

    Liron Tayeb

    VP, R&D

    10+ years experience in medical device development for vascular diseases

    Prev. CEO & VP, R&D at Hyblate Medical and R&D project manager at Edwards Lifesciences

  • Professional woman with short gray hair and glasses, smiling in a navy blazer against a light background.

    Orly Efraty

    VP, MARKETING

    20+ years experience in medical device industry marketing at J&J and Teva Pharmaceuticals

  • A woman with shoulder-length red hair, wearing glasses with a white frame and a black top, smiling at the camera.

    Pazit Waks

    20+ years of building and managing effective QA, QC, and RA systems and teams in the medical device and pharmaceutical industries, including submissions to the FDA and bodies in Europe, Brazil and other jurisdictions

    B.Sc. in Biotechnology and Food Engineering; M.Sc. in QA and Reliability from Technion University

  • Close-up photo of an elderly man with a slight smile, wearing a white shirt, a red tie, and a white coat, against a white background.

    Yair Aloni

    CHAIRMAN

    30+ years of experience in Israeli and international startups

    Several successful exits

  • A middle-aged man with glasses, wearing a suit, white shirt, and a blue tie, is smiling in front of a cloudy sky background.

    Doron Birger

    DIRECTOR (PROPOSED)

    Prev. Chairman, Given Imaging; sold to Medtronic for $1B USD

    Prev. CEO, Elron

    Up for election at next meeting of shareholders on December 12, 2025

  • A woman with long blonde hair sitting indoors near a window with a blurred city background.

    Sophie Galper- Komet

    DIRECTOR

    Founder of Wisdom Star, a boutique consultancy that provides C-level executive corporate services to corporate clients and qualified investors

    Served as board member on numerous TSX and TASE-listed companies

    MBA, Tel Aviv University

    20+ years in capital markets and C-suite roles

  • Portrait of a smiling man with short dark hair, wearing a blue shirt, standing against a gray background.

    Stephen Gledhill

    DIRECTOR

    25+ years in Canadian capital markets, with roles including board, audit committee, CFO roles at public companies

    Recent clients include POSaBIT Systems Corporation (CSE:PBIT), Grown Rogue Inc. (CSE:GRIN), Bhang Corporation (CSE:BHNG), CO2 GRO Inc. (TSXV:GROW), and DelphX Capital Markets Inc. (TSXV:DELX)

  • Portrait of an older male doctor with white hair wearing a white lab coat, standing outdoors.

    Dr. Steve Elias

    MEDICAL ADVISOR

    Director, Center for Vein Disease, Englewood Health, NJ

  • Professional portrait of a middle-aged male doctor wearing a white coat, light blue shirt, and tie, smiling against a gray background.

    Dr. Antonios Gasparis

    MEDICAL ADVISOR

    System Chief, Venous Disease Northwell Health, NY

    Former President, American Venous Forum

  • A woman with curly dark hair wearing glasses and a white lab coat, smiling at the camera.

    Dr. Karem Harth

    MEDICAL ADVISOR

    Director, Center for Comprehensive Venous Care

    University Hospitals Harrington Heart & Vascular Institute

  • A woman with long red hair and glasses, wearing a white coat and a beige top, smiling at the camera.

    Dr. Kathleen Ozsvath

    MEDICAL ADVISOR

    Chief of Vascular Surgery, Albany Medical Center

    Next President of American Venous Forum

  • A smiling middle-aged man in a suit and tie outdoors with greenery in the background.

    Dr. Lowell Kabnick

    MEDICAL ADVISOR

    Clinical Professor of Surgery, NYU Langone Health

    Chancellor of Vein & Lymphatic University

  • Close-up of an older man with glasses and light-colored hair, looking directly at the camera.

    Dr. Ralf Kolvenbach

    MEDICAL ADVISOR

    Chief, Vascular & Endovascular Surgery, SANA, Germany

Person in white lab coat and hairnet using a microscope in a laboratory setting.
VVT Med Announces Acceptance of Procedure Fee for ScleroSafe® in South Korea
Jeff Maser Jeff Maser

VVT Med Announces Acceptance of Procedure Fee for ScleroSafe® in South Korea

"VVT Med" or the "Company"), a developer of innovative minimally invasive solutions for the treatment of venous disease, is pleased to announce that a procedure fee has been accepted in South Korea for treatments performed with ScleroSafe®, marking a significant milestone toward commercial market penetration.

Read More
VVT Med Inc. Engages Independent Trading Group as Market Maker
Jeff Maser Jeff Maser

VVT Med Inc. Engages Independent Trading Group as Market Maker

TORONTO, Aug. 13, 2025 /CNW/ - VVT Med Inc. (TSXV: VVTM) ("VVT" or the "Company"), announces that it has entered into a market making service agreement (the "Agreement") with Independent Trading Group ("ITG") dated August 13, 2025. Pursuant to the Agreement, ITG will provide market-making services in accordance with TSX Venture Exchange (the "TSVX") policies and will trade shares of the Company on the TSXV and all other trading venues with the objective of maintaining a reasonable market and improving the liquidity of the Company's common shares.

Read More